About Swaasa
Swaasa is a company based in Hyderabad (India) founded in 2017 by Narayana Rao Sripada. Swaasa offers products and services including Lung Assessment Test and Swaasa Platform. Swaasa operates in a competitive market with competitors including Medsensio, Docturnal, RESPINOR, Ibrum Technologies and ResApp Health, among others.
- Headquarter Hyderabad, India
- Founders Narayana Rao Sripada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Salcit Technologies Private Limited
- Date of Incorporation 01 Sep, 2017
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$159.22 K (USD)42.19as on Mar 31, 2023
-
Net Profit
$15.81 K (USD)-34.6as on Mar 31, 2023
-
EBITDA
-$21.7 K (USD)-185.54as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Swaasa
Swaasa offers a comprehensive portfolio of products and services, including Lung Assessment Test and Swaasa Platform.
Quick AI-based test for evaluating lung health via cough sounds.
Platform for machine learning-driven respiratory assessments and data security.
Funding Insights of Swaasa
Investors in Swaasa
Swaasa has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include T-Hub.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovation hub connecting startups, corporates, and partners in technology and ecosystem development.
|
Locked | Locked | Locked |
Investor details for Swaasa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Swaasa
Investment portfolio details for Swaasa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Swaasa
Detailed financials for Swaasa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Swaasa Comparisons
Peer comparison for Swaasa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Swaasa
Swaasa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medsensio, Docturnal, RESPINOR, Ibrum Technologies and ResApp Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Respiratory diagnostics are enhanced via a deep learning platform.
|
|
| Locked | Locked | Locked |
Non-invasive solutions for tuberculosis detection and diagnostics are provided.
|
|
| Locked | Locked | Locked |
Real-time diaphragm monitoring devices are provided for medical decision making.
|
|
| Locked | Locked | Locked |
Devices for detecting undiagnosed cardiac and respiratory diseases are developed.
|
|
| Locked | Locked | Locked |
Respiratory diseases are diagnosed digitally from cough and breathing sounds.
|
|
| Locked | Locked | Locked |
Software for sound based cardiopulmonary disease diagnosis
|
Detailed competitors of Swaasa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Swaasa
Complete news archive for Swaasa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swaasa
Swaasa was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Swaasa is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Venkat Yechuri is the current CEO of Swaasa.
Annual revenue of Swaasa is $159.22K as on Mar 31, 2023.
Swaasa was founded in 2017 in Hyderabad, India, within the health technology sector. An AI-driven tool is provided to healthcare providers for respiratory health assessments. Cough sounds are analyzed to support patient diagnoses, with data generated on temperature, oxygen saturation levels, and lung conditions. Operations focus on software integration for clinical use in respiratory care.
Swaasa offers Lung Assessment Test and Swaasa Platform.
Swaasa has 1 investor. Key investors include T-Hub.